Tatsu Shimoyama

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

Chemotherapy Versus Placebo, Gastrointestinal Oncology, Medicine +8

Antibody‐dependent cellular cytotoxicity of cetuximab against tumor cells with wild‐type or mutant epidermal growth factor receptor

Hideharu Kimura, Kazuko Sakai, Tokuzo Arao et al. · Cancer Science · 2007 · 276 citations · Full text

Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients

Sarah Park, Chikako Shimizu, Tatsu Shimoyama et al. · Breast Cancer Research and Treatment · 2006 · 179 citations

Systems Biology, Oncology, Engineering +15

Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells

Y Basaki, Fumihito Hosoi, Yoshinao Oda et al. · Oncogene · 2006 · 166 citations

Y-box-binding Protein 1, Medicine, Akt-dependent Nuclear Localization +7

Establishment of a human non‐small cell lung cancer cell line resistant to gefitinib

Fumiaki Koizumi, Tatsu Shimoyama, Fumiko Taguchi et al. · International Journal of Cancer · 2005 · 158 citations · Full text